Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ORMPORMP
6 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ORAMED PHARMACEUTICALS INC

BANK OF AMERICA CORP /DE/ holds 146,152 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $496,916 as of 2026-Q1. The position was increased (+2.8% shares).

Current Value

$496,916

Current Shares

146,152

Total Value Change

+$91,196

Total Shares Change

-21,501

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
146,152
+2.8%
$496,9160.0%$3.38
17
2025-Q4
Decreased
142,243
-5.0%
$405,3930.0%$2.62
0
2025-Q3
Increased
149,667
+4.4%
$395,1210.0%$2.52
17
2025-Q2
Decreased
143,406
-12.4%
$322,6640.0%$2.00
0
2025-Q1
Decreased
163,695
-2.4%
$350,3070.0%$2.06
0
2024-Q4
New
167,653
-
$405,7200.0%$2.17
36

Other major holders of ORMP: Invesco Ltd., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MERCER GLOBAL ADVISORS INC /ADV

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used